Cancer management in patients with end-stage renal disease - The Eneman/Philips article reviewed

被引:0
作者
Ivy, SP [1 ]
机构
[1] Natl Canc Inst, Invest Drug Branch Canc Therapy Evaluat Program, Rockville, MD USA
来源
ONCOLOGY-NEW YORK | 2005年 / 19卷 / 09期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1212 / 1213
页数:2
相关论文
共 6 条
[1]  
CALVERT AH, 1994, ANTICANCER RES, V14, P2273
[2]   Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: A preliminary report of the national cancer institute organ dysfunction working group [J].
Doroshow, JH ;
Synold, TW ;
Gandara, D ;
Mani, S ;
Remick, SC ;
Mulkerin, D ;
Hamilton, A ;
Sharma, S ;
Ramanathan, RK ;
Lenz, HJ ;
Graham, M ;
Longmate, J ;
Takimoto, CH ;
Ivy, P .
SEMINARS IN ONCOLOGY, 2003, 30 (04) :14-19
[3]   Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden [J].
Edwards, BK ;
Howe, HL ;
Ries, LAG ;
Thun, MJ ;
Rosenberg, HM ;
Yancik, R ;
Wingo, PA ;
Jemal, A ;
Feigal, EG .
CANCER, 2002, 94 (10) :2766-2792
[4]  
Stanta G, 1997, CLIN GERIATR MED, V13, P55
[5]   Chronic kidney disease in the elderly - how to assess risk [J].
Stevens, LA ;
Levey, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (20) :2122-2124
[6]   Administration of oxaliplatin to patients with renal dysfunction: A preliminary report of the National Cancer Institute Organ Dysfunction Working Group [J].
Takimoto, CH ;
Remick, SC ;
Sharma, S ;
Mani, S ;
Ramanathan, RK ;
Doroshow, JH ;
Hamilton, A ;
Mulkerin, D ;
Graham, M ;
Lockwood, GF ;
Ivy, P ;
Egorin, M ;
Greenslade, D ;
Goetz, A ;
Grem, JL .
SEMINARS IN ONCOLOGY, 2003, 30 (04) :20-25